iScience · 2022 · 31 citations · 26 references
EducationNeurobiologyNeuroscienceAgingCell SignalingNeurodegenerationAging PhysiologyBiological AgingCellular AgingLongevityNeurodegenerative DiseasesNeuroprotectionC. Elegans Developmental ModelsMammalian Target Of Rapamycin SignalingMtor Complex 1 SignalingMtor InhibitionMtor SignalingPharmacological ScreeningPi3k-akt-mtor SignalingPolyglutamine Diseases
The Mammalian/mechanistic target of rapamycin (mTOR) played a central role in cellular survival and aging. Inhibition of mTOR had been proposed as a reasonable strategy to promote lifespan and delay age-related diseases in evolutionarily diverse organisms. The study showed that lifespan extension and age-related diseases improvement could be achieved by targeting evolutionarily conserved mTOR pathways and mechanisms using pharmacological interventions. Using this approach in Caenorhabditis elegans, We found that 2 μM Usnic Acid significantly extended the healthy lifespan in wild-type animals. Furthermore, via genetic screen, we showed that Usnic Acid acted on mTOR, which was followed by the activation of PHA-4/Foxa to extend the healthy lifespan. Intriguingly, Usnic Acid also delayed neurodegeneration diseases such as Alzheimer’s and polyglutamine disease through mTOR-dependent manner. Our work suggested that Usnic Acid might be a viable candidate for the prevention and treatment of aging and age-related diseases.
26
NIH Image to ImageJ: 25 years of image analysis
Caroline A Schneider, Wayne Rasband, Kevin W. Eliceiri · Nature Methods · 2012 · 65.2K citations
THE GENETICS OF <i>CAENORHABDITIS ELEGANS</i>
Sydney Brenner · Genetics · 1974 · 15.5K citations · Full text
Life Sciences, Biology, Genetics +14
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Randy Strong, Z. Dave Sharp, James F. Nelson et al. · Nature · 2009 · 3.7K citations · Full text
Genome-wide RNAi screening in Caenorhabditis elegans
Ravi S. Kamath · Methods · 2003 · 1.6K citations